| NCT ID | NCT06476171 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Petrovsky National Research Centre of Surgery |
| Condition | Multiple Organ Dysfunction |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2023-06-19 |
| Primary Completion | 2025-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2023-06-19 with a primary completion date of 2025-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The hypothesis of the study is that hematological indices (neutrophil to lymphocyte ratio, platelet to lymphocyte ratio and systemic index of inflammation) may be predictors of infectious complications and multiple organ dysfunction in patients after cardiac surgery.
Eligibility Criteria
Inclusion Criteria: * age from 18 to 80 years * cardiac surgery * operation in the conditions of cardiopulmonary bypass * availability of voluntary informed consent of the patient to participate in the study Exclusion Criteria: * refusal of the patient from the study * transfer of the patient to another medical institution
Contact & Investigator
Maxim A. Babaev, D.M.
PRINCIPAL INVESTIGATOR
Petrovsky NRCS
Frequently Asked Questions
Who can join the NCT06476171 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Multiple Organ Dysfunction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06476171 currently recruiting?
Yes, NCT06476171 is actively recruiting participants. Contact the research team at maxbabaev@mail.ru for enrollment information.
Where is the NCT06476171 trial being conducted?
This trial is being conducted at Moscow, Russia.
Who is sponsoring the NCT06476171 clinical trial?
NCT06476171 is sponsored by Petrovsky National Research Centre of Surgery. The principal investigator is Maxim A. Babaev, D.M. at Petrovsky NRCS. The trial plans to enroll 200 participants.